August 2009
Clinical Trials News
An ESUN Resource
The Liddy Shriver Sarcoma Initiative maintains searchable abstracts of clinical trials for sarcomas. The following are some of the studies that have been added to open clinical trials since the last issue of ESUN was published:
Phase II
- A Randomized, Double-Blinded, Placebo-Controlled, Multi-Institutional, Phase II.5 Study of AZD0530, a Selective Src Kinase Inhibitor, in Patients With Recurrent Osteosarcoma Localized to the Lung
- Imatinib in Patients With Desmoid Tumor and Chondrosarcoma (Basket 1)
- Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma
- Vorinostat and Bortezomib in Treating Patients With Advanced Soft Tissue Sarcoma
Phase I or Phase I/II
- Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma
- RAD001 in Combination With CP-751,871 in Patients With Advanced Sarcomas and Other Malignant Neoplasms
- A Vaccine Study for High Risk Pediatric Cancers
- Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Not Responded to Treatment
- Ultrasound Hyperthermia Therapy After Implant Radiation Therapy in Treating Patients With Urinary Tract Cancer, Gynecologic Cancer, or Head and Neck Cancer
- A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib, in Adults With Solid Tumors
- A Study to Assess the Safety, Pharmacokinetics, and Potential Effects of Amrubicin on the QT/QTc Interval in Cancer Patients With Advanced Solid Tumors
V6N4 ESUN Copyright © 2009 Liddy Shriver Sarcoma Initiative.